BioXcel Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
BioXcel Therapeutics, Inc.‘s stocks are currently a part of 64 hedge funds’ portfolios, which represents 37.62% of the total amount of its stocks outstanding. This makes up a total of 10.53M shares of BioXcel Therapeutics, Inc.. Compared to the previous quarter, the number fell by -21.61% or -2.90M shares fewer. As for the holding position changes, 28.13% (18) of current hedge fund investors increased the number of shares held, 31.25% (20) of current holders sold a part of the shares held, and 9.38% (6) closed the holdings completely. 17 hedge funds are new holders of BioXcel Therapeutics, Inc. stock in Q1 2023, it is 26.56% of total holders.
Hedge funds holding BioXcel Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 19 |
|---|---|
| Q3 2018 | 18 |
| Q4 2018 | 11 |
| Q1 2019 | 20 |
| Q2 2019 | 35 |
| Q3 2019 | 44 |
| Q4 2019 | 43 |
| Q1 2020 | 68 |
| Q2 2020 | 102 |
| Q3 2020 | 106 |
| Q4 2020 | 114 |
| Q1 2021 | 113 |
| Q2 2021 | 106 |
| Q3 2021 | 100 |
| Q4 2021 | 90 |
| Q1 2022 | 93 |
| Q2 2022 | 92 |
| Q3 2022 | 83 |
| Q4 2022 | 81 |
| Q1 2023 | 64 |
Hedge funds changes in BioXcel Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 5 | 6 | 8 | -5 |
|---|---|---|---|---|---|
| Q3 2018 | 6 | 4 | 4 | 7 | -3 |
| Q4 2018 | 0 | 4 | 5 | 7 | -5 |
| Q1 2019 | 11 | 4 | 4 | 2 | -1 |
| Q2 2019 | 18 | 10 | 4 | 3 | 0 |
| Q3 2019 | 11 | 21 | 4 | 2 | 6 |
| Q4 2019 | 9 | 18 | 7 | 10 | -1 |
| Q1 2020 | 34 | 16 | 17 | 8 | -7 |
| Q2 2020 | 44 | 33 | 20 | 9 | -4 |
| Q3 2020 | 25 | 50 | 21 | 22 | -12 |
| Q4 2020 | 25 | 46 | 30 | 17 | -4 |
| Q1 2021 | 18 | 50 | 31 | 19 | -5 |
| Q2 2021 | 23 | 36 | 33 | 30 | -16 |
| Q3 2021 | 11 | 49 | 24 | 17 | -1 |
| Q4 2021 | 14 | 38 | 22 | 23 | -7 |
| Q1 2022 | 17 | 32 | 27 | 13 | 4 |
| Q2 2022 | 16 | 32 | 27 | 16 | 1 |
| Q3 2022 | 6 | 33 | 28 | 15 | 1 |
| Q4 2022 | 15 | 23 | 28 | 17 | -2 |
| Q1 2023 | 17 | 18 | 20 | 6 | 3 |
Hedge funds changes in BioXcel Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 4,061,000 | 4,364,000 |
| Q2 2020 | 27,319,000 | 13,277,000 |
| Q3 2020 | 23,347,000 | 7,134,000 |
| Q4 2020 | 28,836,000 | 11,855,000 |
| Q1 2021 | 11,303,000 | 10,475,000 |
| Q2 2021 | 4,936,000 | 7,940,000 |
| Q3 2021 | 6,539,000 | 6,840,000 |
| Q4 2021 | 4,800,000 | 2,878,000 |
| Q1 2022 | 3,462,000 | 4,401,000 |
| Q2 2022 | 2,114,000 | 1,682,000 |
| Q3 2022 | 2,556,000 | 933,000 |
| Q4 2022 | 3,208,344 | 1,348,500 |
| Q1 2023 | 76,942,000 | 84,272,000 |